QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.057174v1 307/3/1205    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, P.-Y. Articles by Morgan, E. T. Search for Related Content PubMed PubMed Citation Articles by Cheng, P.-Y. Articles by Morgan, E. T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CURCUMIN

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Rapid Transcriptional Suppression of Rat Cytochrome P450 Genes by Endotoxin Treatment and Its Inhibition by Curcumin

Department of Pharmacology, School of Medicine (P.-Y.C., E.T.M.) and Department of Biostatistics, School of Public Health (M.W.), Emory University, Atlanta, Georgia

Down-regulation of constitutive hepatic cytochrome P450 (P450) mRNAs by bacterial endotoxin (lipopolysaccharide, LPS) or other inflammatory stimuli has been documented extensively, but the contribution of transcriptional suppression to this effect is poorly understood. Here, we demonstrate that the rates of transcription of the CYP2C11, CYP3A2, and CYP2E1 genes are reduced to 20, 30, and 10% of control levels, respectively, in rat liver within 1 to 2 h of injection of LPS (1 mg/kg). The magnitude and rapidity of these effects indicate that transcriptional suppression is a primary reason for the decline in P450 mRNAs. Injection of curcumin significantly inhibited the rapid transcriptional suppression of CYP2E1, and blocked that of CYP3A2. These effects seemed to be independent of inhibition of nuclear factor-B (NF-B) activation by curcumin, because induction of known NF-B-regulated genes was not attenuated. One hour after LPS injection, the DNA-binding activities of hepatocyte nuclear factor (HNF)1, HNF3, and HNF4 were reduced to 73, 72, and 53%, respectively, of control values. The nuclear abundances of Sp1, liver-enriched transcriptional inhibitory protein (LIP), HNF1, and HNF3 were unchanged, whereas the abundance of HNF4 was reduced to 87% of control levels. We conclude that changes in Sp1 or LIP do not contribute significantly to the early suppression of P450 transcription in the acute phase rat liver. Although changes in DNA-binding activities of HNF1, HNF3, and HNF4 are too small individually to explain the observed changes in P450 transcription, the role of each factor in concert with other factors remains to be determined.

Address correspondence to: Dr. Edward T. Morgan, Department of Pharmacology, Emory University, Atlanta, GA 30322. E-mail: etmorga{at}emory.edu

This article has been cited by other articles:

				R. M. Sawaya and D. S. Riddick Cytochrome P450 2C11 5'-Flanking Region and Promoter Mediate in Vivo Suppression by 3-Methylcholanthrene Drug Metab. Dispos., September 1, 2008; 36(9): 1803 - 1811. [Abstract] [Full Text] [PDF]

				Y. Masubuchi, K. Enoki, and T. Horie Down-Regulation of Hepatic Cytochrome P450 Enzymes in Rats with Trinitrobenzene Sulfonic Acid-Induced Colitis Drug Metab. Dispos., March 1, 2008; 36(3): 597 - 603. [Abstract] [Full Text] [PDF]

				E. T. Morgan, K. B. Goralski, M. Piquette-Miller, K. W. Renton, G. R. Robertson, M. R. Chaluvadi, K. A. Charles, S. J. Clarke, M. Kacevska, C. Liddle, et al. Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer Drug Metab. Dispos., February 1, 2008; 36(2): 205 - 216. [Abstract] [Full Text] [PDF]

				R. Ghose, D. White, T. Guo, J. Vallejo, and S. J. Karpen Regulation of Hepatic Drug-Metabolizing Enzyme Genes by Toll-Like Receptor 4 Signaling Is Independent of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein Drug Metab. Dispos., January 1, 2008; 36(1): 95 - 101. [Abstract] [Full Text] [PDF]

				A. E. Aitken and E. T. Morgan Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes Drug Metab. Dispos., September 1, 2007; 35(9): 1687 - 1693. [Abstract] [Full Text] [PDF]

				J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, J. F. Maddox, P. E. Ganey, and R. A. Roth Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine Toxicol. Sci., April 1, 2006; 90(2): 569 - 585. [Abstract] [Full Text] [PDF]

				M. A. Abdelmegeed, N. J. Carruthers, K. J. Woodcroft, S. K. Kim, and R. F. Novak Acetoacetate Induces CYP2E1 Protein and Suppresses CYP2E1 mRNA in Primary Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 203 - 213. [Abstract] [Full Text] [PDF]

				T. A. Richardson and E. T. Morgan Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 703 - 709. [Abstract] [Full Text] [PDF]

				Y. Lu, X. Wang, and A. I. Cederbaum Lipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazole Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G308 - G319. [Abstract] [Full Text] [PDF]

				D. S. Riddick, C. Lee, A. Bhathena, Y. E. Timsit, P.-Y. Cheng, E. T. Morgan, R. A. Prough, S. L. Ripp, K. K. M. Miller, A. Jahan, et al. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS Drug Metab. Dispos., April 1, 2004; 32(4): 367 - 375. [Abstract] [Full Text] [PDF]